Table 1.
Frequency of BRD4-NUT fusions in advanced cancer cases.
| Disease | Disease Count | Count | % of BRD4-NUT | % of Disease |
|---|---|---|---|---|
| lung non-small cell lung carcinoma (nsclc-nos) | 4996 | 7 | 22.58% | 0.14% |
| lung squamous cell carcinoma (nsclc-scc) | 4895 | 5 | 16.13% | 0.10% |
| nut midline carcinoma | 15 | 5 | 16.13% | 33.33% |
| skin adnexal carcinoma | 135 | 2 | 6.45% | 1.48% |
| lung small cell undifferentiated carcinoma (sclc) | 1723 | 1 | 3.23% | 0.06% |
| nasopharynx and paranasal sinuses squamous cell carcinoma (scc) | 92 | 1 | 3.23% | 1.09% |
| unknown primary (nos) | 817 | 1 | 3.23% | 0.12% |
| testis germ cell tumor (non-seminoma) | 108 | 1 | 3.23% | 0.93% |
| salivary gland carcinoma (nos) | 294 | 1 | 3.23% | 0.34% |
| unknown primary melanoma | 2590 | 1 | 3.23% | 0.04% |
| nasopharynx and paranasal sinuses undifferentiated carcinoma | 177 | 1 | 3.23% | 0.56% |
| trachea squamous cell carcinoma (scc) | 6 | 1 | 3.23% | 16.67% |
| breast carcinoma (nos) | 9459 | 1 | 3.23% | 0.01% |
| unknown primary germ cell tumor | 28 | 1 | 3.23% | 3.57% |
| head and neck squamous cell carcinoma (hnscc) | 2245 | 1 | 3.23% | 0.04% |
| thymus carcinoma | 294 | 1 | 3.23% | 0.34% |
| All | 181,838 | 31 | 100.00% | 0.02% |